KRAS and cancer: KRAS(G12V) expression was dose dependent and, for subsequent autophagy analysis, we systematically adjusted the concentration and fine-tuned the induction duration to achieve an expression level comparable to that of endogenous RAS in various cancer cell lines (Fig. 1a, b).